Wolverine Asset Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-251,104
| Closed | -$2.54M | – | 2051 |
|
|
2022
Q4 | $2.54M | Hold |
251,104
| – | – | 0.03% | 325 |
|
|
2022
Q3 | $2.49M | Hold |
251,104
| – | – | 0.03% | 354 |
|
|
2022
Q2 | $2.49M | Buy |
251,104
+85,170
| +51% | +$843K | 0.02% | 359 |
|
|
2022
Q1 | $1.64M | Buy |
165,934
+281
| +0.2% | +$2.77K | 0.02% | 438 |
|
|
2021
Q4 | $1.63M | Sell |
165,653
-10,954
| -6% | -$108K | 0.02% | 442 |
|
|
2021
Q3 | $1.72M | Sell |
176,607
-9,168
| -5% | -$89.3K | 0.01% | 383 |
|
|
2021
Q2 | $1.8M | Buy |
185,775
+184,102
| +11,004% | +$1.78M | 0.01% | 332 |
|
|
2021
Q1 | $16K | Buy |
+1,673
| New | +$16K | ﹤0.01% | 1536 |
|